LSPedia has secured a strategic growth investment from Bregal Sagemount's Basecamp fund, marking a significant milestone for the pharmaceutical compliance software provider. This funding will fuel continued product innovation, customer expansion, and accelerate LSPedia's global growth strategy. While the exact investment amount is undisclosed, the company's focus on mission-critical compliance and traceability software positions it for further market penetration.
